- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
NIH to offer radiology CRADAs
The radiology department of the National Institutes of Health Clinical Center is seeking Cooperative Research and Development Agreements (CRADAs) with one or more medical equipment manufacturers. The CRADAs, which enable the NIHCC and companies to
The radiology department of the National Institutes of Health Clinical Center is seeking Cooperative Research and Development Agreements (CRADAs) with one or more medical equipment manufacturers. The CRADAs, which enable the NIHCC and companies to collaborate on research projects, cover MRI, MR spectroscopy, molecular imaging, image processing, and image-guided surgery.
The objective of the project is the rapid publication of research findings and the timely commercialization of improved diagnostic and treatment strategies. Particular emphasis is placed on discoveries that enhance clinical research, according to the NIHCC. While the NIHCC does not contribute funding, the center can offer collaborators access to facilities, staff, materials, and expertise.
Collaborators can also elect an option to be an exclusive or nonexclusive licensee to government intellectual property rights arising under the CRADA and may qualify as a co-inventor of new technology that is developed under the agreement. For more information, contact Steve Galen at 301/594-4509. Statements of interest must be received by Dec. 10, with formal proposals due 30 days later.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
